VIRX · Categories · 8-K
VIRX - SEC Form 8-K filings
Viracta Therapeutics Inc. (VIRX) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for VIRX
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update, Other Events, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- SEC Form 8-K filed by Viracta Therapeutics Inc.8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Other Events8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- SEC Form 8-K filed by Viracta Therapeutics Inc.8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits (Amendment)8-K/A - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- SEC Form 8-K filed by Viracta Therapeutics Inc.8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Leadership Update8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- Viracta Therapeutics Inc. filed SEC Form 8-K: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- SEC Form 8-K filed by Viracta Therapeutics Inc.8-K - Viracta Therapeutics, Inc. (0001061027) (Filer)
- SEC Form 8-K/A filed by Viracta Therapeutics Inc.8-K/A - Viracta Therapeutics, Inc. (0001061027) (Filer)